SEC Form D private-offering filing

Gilgamesh Pharma Inc.

Name: Gilgamesh Pharma Inc. - new SEC Form D private-offering filing, New York, NY
Published: 2026-03-31

A new SEC Form D private-offering notice from New York, NY, a $15,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Gilgamesh Pharma Inc. site↗ Verified via SEC Form D

Clinical stage biotech developing psychedelic derived drugs for depression, PTSD and other mental health disorders.

Filed 2026-03-31Filed to raise $15,000,000First money in 2026-03-27Raised so far $2,250,000HQ (as filed) New York, NYSector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified gilgameshpharmaceutical.com↗Named in the filing 6 executives & directors

Open this row on the live feed →More new filings in New York →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.